Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma

Programmed Death Ligand 1: A Poor Prognostic Marker in Endometrial Carcinoma

Endometrial carcinoma is the only gynaecologic malignancy with a raising incidence and mortality, posing a major health concern worldwide. The upregulation of programmed death ligand 1 (PD-L1) on tumour cells causes T-cell suppression, which impedes antitumour immunity, promotes immune cell evasion...

Full description

Bibliographic Details
Main Authors: Mianxin Chew, Yin Ping Wong, Norain Karim, Muaatamarulain Mustangin, Nurwardah Alfian, Geok Chin Tan
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Diagnostics
Subjects:
endometrial carcinoma
PD-L1
prognostic factor
gynaecology
pathology
Online Access:https://www.mdpi.com/2075-4418/10/6/394

Internet

https://www.mdpi.com/2075-4418/10/6/394

Similar Items